These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 9450174

  • 1. Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer.
    Tomeczko J, Napora P, Dlubek D, Pacuszko T, Bochenska J, Teucher T, Schmitz H, Lange A.
    Arzneimittelforschung; 1997 Dec; 47(12):1411-6. PubMed ID: 9450174
    [Abstract] [Full Text] [Related]

  • 2. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, Ryan C, Priest K, Bromelow KV, Palmer RD, Tuckwell N, Kennard DA, Souberbielle BE.
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S, Nagato K, Kunii N, Yamamoto H, Yamasaki K, Okita K, Hanaoka H, Shimizu N, Suzuki M, Yoshino I, Taniguchi M, Fujisawa T, Nakayama T.
    J Immunol; 2009 Feb 15; 182(4):2492-501. PubMed ID: 19201905
    [Abstract] [Full Text] [Related]

  • 10. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.
    Petersen RP, Pham D, Burfeind WR, Hanish SI, Toloza EM, Harpole DH, D'Amico TA.
    Ann Thorac Surg; 2007 Apr 15; 83(4):1245-9; discussion 1250. PubMed ID: 17383320
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA, McGinnis WL, Stella PJ, Marschke RF, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA.
    Cancer; 1998 Mar 15; 82(6):1037-48. PubMed ID: 9506347
    [Abstract] [Full Text] [Related]

  • 14. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z, Xu F, Wang S, Li N, Wang C.
    Lung Cancer; 2008 Jun 15; 60(3):434-40. PubMed ID: 18036699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Yamaguchi K, Fukuhara S.
    J Cancer Res Clin Oncol; 2002 Jan 15; 128(1):29-36. PubMed ID: 11862469
    [Abstract] [Full Text] [Related]

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 15; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 18. Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
    Douillard JY, Peschel C, Shepherd F, Paz-Ares L, Arnold A, Davis M, Tonato M, Smylie M, Tu D, Voi M, Humphrey J, Ottaway J, Young K, Vreckem AV, Seymour L.
    Lung Cancer; 2004 Dec 15; 46(3):361-8. PubMed ID: 15541822
    [Abstract] [Full Text] [Related]

  • 19. Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
    Bolonaki I, Kotsakis A, Papadimitraki E, Aggouraki D, Konsolakis G, Vagia A, Christophylakis C, Nikoloudi I, Magganas E, Galanis A, Cordopatis P, Kosmatopoulos K, Georgoulias V, Mavroudis D.
    J Clin Oncol; 2007 Jul 01; 25(19):2727-34. PubMed ID: 17602077
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.